(Q36996546)

17 August 2017

1 reference

title

Clinical presentation and treatment of type 2 diabetes in children (English)

1 reference

17 August 2017

1 reference

1

Orit Pinhas-Hamiel

0 references

author name string

Phil Zeitler

series ordinal

2

1 reference

17 August 2017

publication date

1 December 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

8 Suppl 9

1 reference

17 August 2017

page(s)

16-27

1 reference

The classification of diabetes by clinical and C-peptide criteria. A prospective population-based study.

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

Autoimmunity to islet proteins in children diagnosed with new-onset diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

The global spread of type 2 diabetes mellitus in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

The type 2 family: a setting for development and treatment of adolescent type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

Beta-cell autoantibodies in children with type 2 diabetes mellitus: subgroup or misclassification?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

Characteristics of youth-onset noninsulin-dependent diabetes mellitus and insulin-dependent diabetes mellitus at diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

Early presentation of type 2 diabetes in Mexican-American youth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

Diabetic ketoacidosis among obese African-American adolescents with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

Hyperosmolar hyperglycemic crisis: an acute life-threatening event in children and adolescents with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

Acute necrotizing pancreatitis in an adolescent with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

Diabetic ketoacidosis, hyperosmolarity and hypernatremia: are high-carbohydrate drinks worsening initial presentation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

Hyperglycemic hyperosmolar non-ketotic syndrome in children with type 2 diabetes*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

Physical training, lifestyle education, and coronary risk factors in obese girls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

Effects of a low-carbohydrate diet on weight loss and cardiovascular risk factor in overweight adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

A reduced-glycemic load diet in the treatment of adolescent obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

Benefit and risk of exercise on myocardial function in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

A randomized controlled trial of resistance exercise training to improve glycemic control in older adults with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

A lifestyle intervention improves plasma insulin levels among Native American high school youth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

Effects of resistance training on insulin sensitivity in overweight Latino adolescent males

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

Daily walking combined with diet therapy is a useful means for obese NIDDM patients not only to reduce body weight but also to improve insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

Ten-year outcomes of behavioral family-based treatment for childhood obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

Dropout of young non-insulin-dependent diabetics from diabetic care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

Oral antihyperglycemic therapy for type 2 diabetes: scientific review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

Metformin: new understandings, new uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

Risk of Fatal and Nonfatal Lactic Acidosis With Metformin Use in Type 2 Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

Clinical evidence of thiazolidinedione-induced improvement of pancreatic beta-cell function in patients with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

Effect of thiazolidinediones on body weight in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

Effect of pioglitazone on biochemical indices of non-alcoholic fatty liver disease in upper body obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

The role of sulphonylureas in the management of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

Insulinotropic meglitinide analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00330.X

10.1111/J.1399-5448.2007.00330.X

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference